90
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Analysis of alternative splicing in chicken macrophages transfected with overexpression/knockdown of RIP2 gene

, , &

References

  • Mifflin L, Ofengeim D, Yuan J. Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat Rev Drug Discov. 2020;19(8):553–571.
  • Honjo H, Watanabe T, Kamata K, Minaga K, Kudo M. RIPK2 as a new therapeutic target in inflammatory bowel diseases. Front Pharmacol. 2021;12:650403.
  • Yang Q, Tian S, Liu Z, Dong W. Knockdown of RIPK2 inhibits proliferation and migration, and induces apoptosis via the NF-κB signaling pathway in gastric cancer. Front Genet. 2021;12:627464.
  • Pellegrini E, Desfosses A, Wallmann A, et al. RIP2 filament formation is required for NOD2 dependent NF-κB signalling. Nat Commun. 2018;9(1):4043.
  • Yan Y, Zhou B, Qian C, et al. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis. Nat Commun. 2022;13(1):669.
  • Ermine K, Yu J, Zhang L. Role of receptor interacting protein (RIP) kinases in cancer. Genes Dis. 2022;9(6):1579–1593.
  • Jun JC, Cominelli F, Abbott DW. RIP2 activity in inflammatory disease and implications for novel therapeutics. J Leukoc Biol. 2013;94(5):927–932.
  • Poudel B, Gurung P. Allergic asthma: RIPK2 takes the lead. J Leukoc Biol. 2018;104(3):441–443.
  • Li D, Tang L, Liu B, Xu S, Jin M, Bo W. RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma. Aging (Albany NY). 2021;13(7):10450–10467.
  • Zare A, Petrova A, Agoumi M, et al. Erratum: RIPK2: new elements in modulating inflammatory breast cancer pathogenesis (Cancers, (2018) 10, (184),. Cancers. 2018;10(11):184.
  • Sun H, Li N, Tan J, et al. Transcriptional regulation of RIP2 gene by NFIB is associated with cellular immune and inflammatory response to APEC infection. Int J Mol Sci. 2022;23(7):3814.
  • Haussmann IU, Bodi Z, Sanchez-Moran E, et al. M6 A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature. 2016;540(7632):301–304.
  • Baralle FE, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18(7):437–451.
  • Cardinali B, Cappella M, Provenzano C, et al. MicroRNA-222 regulates muscle alternative splicing through Rbm24 during differentiation of skeletal muscle cells. Cell Death Dis. 2016;7(2):e2086.
  • Castro MAA, Oliveira MI, Nunes RJ, et al. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse. J Immunol. 2007;178(7):4351–4361.
  • Montes M, Sanford BL, Comiskey DF, Chandler DS. RNA splicing and disease: animal models to therapies. Trends Genet. 2019;35(1):68–87.
  • López-Martínez A, Soblechero-Martín P, De-La-Puente-Ovejero L, Nogales-Gadea G, Arechavala-Gomeza V. An overview of alternative splicing defects implicated in myotonic dystrophy type i. Genes. 2020;11(9):1–27.
  • Lejman J, Zieliński G, Gawda P, Lejman M. Alternative splicing role in new therapies of spinal muscular atrophy. Genes . 2021;12(9):1–17.
  • Buskin A, Zhu L, Chichagova V, et al. Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa. Nat Commun. 2018;9(1):4234.
  • Igreja S, Clarke LA, Botelho HM, Marques L, Amaral MD. Correction of a cystic fibrosis splicing mutation by antisense oligonucleotides. Hum Mutat. 2016;37(2):209–215.
  • La Cognata V, D’Agata V, Cavalcanti F, Cavallaro S. Splicing: is there an alternative contribution to Parkinson’s disease? Neurogenetics. 2015;16(4):245–263.
  • Brue T, Camper SA. Novel mechanism of pituitary hormone deficiency: genetic variants shift splicing to produce a dominant negative transcription factor isoform. Eur J Endocrinol. 2021;185(6):C19–C25.
  • Bielli P, Busà R, Di Stasi SM, et al. The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. EMBO Rep. 2014;15(4):419–427.
  • Yin X, Krikorian P, Logan T, Csizmadia V. Induction of RIP-2 kinase by proinflammatory cytokines is mediated via NF-κB signaling pathways and involves a novel feed-forward regulatory mechanism. Mol Cell Biochem. 2010;333(1–2):251–259.
  • Sun H, Chen T, Wu Y, Sun C, Li H. Construction of Gallus gallus RIPK2 gene lentiviral interference vector and screening of HD11 with stably low expressing RIPK2e. J Agric Biotechnol. 2022;30(6):1031–1042.
  • Sun H, Li H, Yang Y, Cao Y, Tan J, Li N. Transcriptome alterations in chicken HD11 cells with steady knockdown and overexpression of RIPK2 gene. Poult Sci. 2023;102(1):102263.
  • Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013;31(1):46–53.
  • Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.
  • Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1–13.
  • Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
  • Jiang W, Chen L. Alternative splicing: human disease and quantitative analysis from high-throughput sequencing. Comput Struct Biotechnol J. 2021;19:183–195.
  • Mazin PV, Khaitovich P, Cardoso-Moreira M, Kaessmann H. Alternative splicing during mammalian organ development. Nat Genet. 2021;53(6):925–934.
  • Nikonova E, Kao SY, Spletter ML. Contributions of alternative splicing to muscle type development and function. Semin Cell Dev Biol. 2020;104:65–80.
  • Su Z, Huang D. Alternative splicing of pre-mrna in the control of immune activity. Genes (Basel). 2021;12(4):1–15.
  • Reviejo M, Soto M, Lozano E, et al. Impact of alternative splicing on mechanisms of resistance to anticancer drugs. Biochem Pharmacol. 2021;193:114810.
  • Wu F, Chen Q, Liu C, et al. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma. Cancer Med. 2020;9(6):2171–2180.
  • Gao C, Zhai J, Dang S, Zheng S. Analysis of alternative splicing in chicken embryo fibroblasts in response to reticuloendotheliosis virus infection. Avian Pathol. 2018;47(6):585–594.
  • Li X, Yang KB, Chen W, et al. CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. Autophagy. 2021;17(12):4323–4340.
  • Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19(1):12.
  • Ichimiya T, Yamakawa T, Hirano T, et al. Autophagy and autophagy‐related diseases: a review. Int J Mol Sci. 2020;21(23):1–21.
  • Stavoe AKH, Holzbaur ELF. Autophagy in neurons. Annu Rev Cell Dev Biol. 2019;35:477–500.
  • Doherty J, Baehrecke EH. Life, death and autophagy. Nat Cell Biol. 2018;20(10):1110–1117.
  • Homer CR, Kabi A, Marina-Garci N, et al. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy. J Biol Chem. 2012;287(30):25565–25576.
  • Anand PK, Tait SWG, Lamkanfi M, et al. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J Biol Chem. 2011;286(50):42981–42991.
  • Song M, Yeku OO, Rafiq S, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11(1):6298.
  • Wu B, Song M, Dong Q, et al. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced PDL1 transcription in triple negative breast cancer. Theranostics. 2022;12(11):5086–5102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.